PT - JOURNAL ARTICLE AU - Dixon, Justin AU - Dhodho, Efison AU - Mundoga, Fionah AU - Webb, Karen AU - Chimberengwa, Pugie AU - Mhlanga, Trudy AU - Nhapi, Tatenda AU - Chinyanga, Theonevus Tinashe AU - Mudavanhu, Justice AU - Nkala, Lee AU - Nyabereka, Ronald AU - Gwati, Gwati AU - Shambira, Gerald AU - Zaranyika, Trust AU - Chandler, Clare I.R. AU - Ferrand, Rashida A. AU - Ndhlovu, Chiratidzo Ellen TI - Assembling the Challenge of Multimorbidity in Zimbabwe: A Participatory Ethnographic Study AID - 10.1101/2024.08.06.24311557 DP - 2024 Jan 01 TA - medRxiv PG - 2024.08.06.24311557 4099 - http://medrxiv.org/content/early/2024/08/07/2024.08.06.24311557.short 4100 - http://medrxiv.org/content/early/2024/08/07/2024.08.06.24311557.full AB - Multimorbidity, increasingly recognised as a global health challenge, has recently emerged on the health agendas of many lower-income countries, including in Africa. Yet with its conceptual origins in the global North, its meaning and possible utility for stakeholders in lower-resources settings remains abstract. This study drew together policymakers, public health practitioners, academics, health informaticians, health professionals, and people living with multimorbidity (PLWMM) in Zimbabwe to understand: What is the transformative potential and possible limitations of elevating multimorbidity as a priority in this setting? To bring these different perspectives into conversation, we used a participatory ethnographic design that involved a health facility survey, participant-observation, in-depth interviews, audio-visual diaries, and participatory workshops. Multimorbidity, we found, was new to many respondents but generally viewed as a meaningful and useful concept. It foregrounded a range of challenges related to the ‘vertical’ organisation and uneven funding of different diseases, while revealing promising opportunities for integration across entrenched silos of knowledge and practice. However, with capacity and momentum to address multimorbidity currently concentrated within the HIV programme, there was concern that multimorbidity could itself become verticalized, undercutting its transformative potential. Participants agreed that responding to multimorbidity requires a decisive shift from vertical, disease-centred programming to restore the comprehensive primary care that undergirded Zimbabwe’s once-renowned health system. It also means building a policy-enabling environment that values generalist (as well as specialist) knowledge, ground-level experience, and inclusive stakeholder engagement. The ‘learning’ health system, we conclude, represents a promising conceptual lens for unifying these imperatives, providing a tangible framework for how knowledge, policy, and practice synergise within more self-reliant, person-centred health systems able to respond to ever-evolving complex health challenges like multimorbidity.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was funded by a Wellcome Trust Research Fellowship in Humanities and Social Sciences (Multimorbidity and Knowledge Architectures: An Interdisciplinary Global Health Collaboration, grant ref. 222177, to JD). The research was embedded within OPHID Target, Accelerate and Sustain Quality Care (TASQC) for HIV Epidemic Control (grant ref. 72061320CA00005) with support from the Presidents Emergency Plan for AIDS Relief (PEPFAR) through USAID (to ED, KW, PC, TM, TN and TTC).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval was sought from the Medical Research Council of Zimbabwe (MRCZ/A/2842), Joint Research Ethics Committee of the Parirenyatwa Group of Hospitals and university of Zimbabwe College of Health Sciences (386/2021), the City of Harare, and the London School of Hygiene and Tropical Medicine (26469).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesData from the study has been deposited with the United Kingdom Data Service (UKDS). We have included all transcripts (in-depth interviews), health facility survey data, and second-order summaries of fieldnotes from observational work. In line with our ethical approval, we have excluded raw fieldnotes, workshop discussions, and audio-visual diaries due to the challenges in maintaining confidentiality. The DOI for the data in UKDS is: https://doi.org/10.5255/UKDA-SN-857310. https://doi.org/10.5255/UKDA-SN-857310